US firms Large Scale Biology Corp and privately-held Planet
Biotechnology have expanded their biomanufacturing program to
extract and purify the latter's lead product, CaroRx, a plant-made
antibody to control dental caries.
A new gene scanning technology, developed by researchers in the UK,
is set to have a major impact on healthcare in the future with the
potential to lead a very personalised genetic profile relevant to
drug prescribing, leading to...
Affymetrix has signed an agreement to acquire ParAllele Bioscience
- a move intended to broaden its variety of microarray
applications. This acquisition builds on a two-year collaboration
between the two companies.
A new signature genetics tool, which allows doctors to personalise
drug therapy, could well have the potential to personalise a
patient's drug regimen based on his/her genetic makeup to minimise
side effects and maximise drug...
A team of gene researchers has sequenced the entire length of the
X-chromosome, providing a starting point to explore the biological
differences between men and woman and a plethora of genes
implicated in human diseases.
Pharming of the Netherlands, which is pioneering the use of
transgenic animals for the production of biologics, has raised €7
million in new funding and will use the proceeds to advance its
portfolio of clinical drug candidates.
A technique used to conduct fully automated high throughput
mutation detection in microbial genomes, has shown greater
sensitivity over existing methods. The method analyses genetic
modification in bacteria and other disease causing...
Applied Biosystems has announced the introduction of a new workflow
management and process automation solution software that integrates
data form multiple sources for genomics and proteomics